Come up with a name for your new list and we'll add to it:
Sol-Gel raised a round of funding on January 01, 2002. Investors include
Merck KGaA - German Consumer Health Business.
Sol-Gel develops and commercializes a micro-encapsulation process permitting the controlled release of almost any organic or bio-organic molecule enclaved in a sol gel capsule. Sol-Gel targets variou…